SABBY MANAGEMENT, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001535610
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 15 positions · Total reported value $4.50M · Top-10 concentration 87.0% · Updated 2026-11-13
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
Turnover: 88.0% · 7 new · 5 cut · 10 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -12.6% · vs SPY -14.8% · Prev Value $13.73M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -21.2% · vs SPY -23.4% · Latest Value $4.50M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, SABBY MANAGEMENT, LLC disclosed 15 equity positions with a combined reported value of $4.50M. The filing implies a focused portfolio: its ten largest positions account for 87.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were PN ($737.06K), YXT ($646.55K), CRVO ($593.04K). By sector, the heaviest allocations are Health Care 45.4%, Information Technology 36.5%. Versus the prior quarter, allocation shifted toward Information Technology (+30.5pp), Health Care (+15.4pp) and away from Consumer Staples (-6.1pp), Consumer Discretionary (-23.1pp).
Versus the prior quarter, SABBY MANAGEMENT, LLC opened 7 new positions, trimmed 5 and fully exited 10, a turnover rate of 88.0% of positions. The portfolio's overlap with the prior quarter was 32% of names.
The largest new positions opened in Q3 2026 were PN ($737.06K), YXT ($646.55K), APVO ($423.50K).
Of the 10 positions fully exited versus the prior quarter, the largest were SPY ($4.11M), ABVX ($1.09M), FAMI ($840.31K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
Fully Exited (vs previous quarter)
- SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $4.11M
- ABVX ABIVAX SA · prev qtr: $1.09M
- FAMI FARMMI INC · prev qtr: $840.31K
- TPST TEMPEST THERAPEUTICS INC · prev qtr: $567.53K
- BIAF BIOAFFINITY TECHNOLOGIES INC · prev qtr: $296.90K
- CREG SMART POWERR CORP · prev qtr: $263.21K
- BCTX BRIACELL THERAPEUTICS CORP · prev qtr: $261.54K
- INM InMed Pharmaceuticals Inc · prev qtr: $69.70K
Insider Transactions (Form 4)
Latest SABBY MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Sabby Management files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 18 positions worth $13.73M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 18 positions · $13.73M reported value (Q2 2026)
- Top 10 holdings = 91.9% of reported value
- Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 29.9%
- Average position size: $762.56K
Sector Tilt
- Health Care 30.0%
- Consumer Discretionary 25.5%
- Consumer Staples 6.1%
- (classified holdings cover 70% of value)
Quarterly Activity
- Q2 2026: 7 new, 7 added, 4 reduced, 15 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
269.00K | $737.06K | 16.38% | New | |
| 2 |
|
286.08K | $646.55K | 14.37% | New | |
| 3 |
|
199.68K | $593.04K | 13.18% | Reduce | |
| 4 |
|
232.69K | $423.50K | 9.41% | New | |
| 5 |
|
864 | $375.84K | 8.35% | Add | |
| 6 |
|
1.00K | $277.89K | 6.17% | New | |
| 7 |
|
64.67K | $260.62K | 5.79% | Reduce | |
| 8 |
|
313.13K | $211.90K | 4.71% | Add | |
| 9 |
|
308.36K | $202.59K | 4.50% | New | |
| 10 |
|
85.21K | $187.46K | 4.17% | New | |
| 11 |
|
136.37K | $158.18K | 3.52% | Reduce | |
| 12 |
|
85.91K | $155.49K | 3.46% | Add | |
| 13 |
|
1.00K | $107.61K | 2.39% | Reduce | |
| 14 |
|
126.92K | $103.69K | 2.30% | Reduce | |
| 15 |
|
442 | $58.48K | 1.30% | New | |
FAQ
What did SABBY MANAGEMENT, LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, SABBY MANAGEMENT, LLC reported 15 equity positions worth $4.50M in aggregate; its largest disclosed positions were PN ($737.06K), YXT ($646.55K), CRVO ($593.04K).
How large is SABBY MANAGEMENT, LLC's portfolio?
SABBY MANAGEMENT, LLC reported $4.50M of long equity holdings across 15 positions as of 2026-Q3. Top-10 holdings account for 87.0% of reported value.
What is SABBY MANAGEMENT, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.